Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5885 USD | -1.59% | -2.63% | -21.07% |
May. 15 | Traws Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 07 | Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.07% | 12.61M | |
+45.37% | 56.65B | |
-6.85% | 39.44B | |
+39.19% | 39.03B | |
-6.65% | 26.86B | |
+12.37% | 26.75B | |
-21.01% | 19.03B | |
+0.88% | 12.28B | |
+24.57% | 12.26B | |
+26.93% | 12.04B |
- Stock Market
- Equities
- TRAW Stock
- News Traws Pharma, Inc.
- Onconova Therapeutics : Noble Capital Upgrades Onconova Therapeutics to Outperform From Market Perform, Adjusts Price Target to $0.46 From $0.30